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Abstract
Patients with far advanced colorectal cancers received chemotherapy consisting of low-dose
cyclophosphamide (LDCY) 333 mg/m2 every four weeks intravenously and by oral administration
of 5’-DFUR (a masked compound of 5-Fluorouracil). Serum levels of immunosuppressive acidic
protein (IAP), an acute phase protein, were measured every four weeks for a total of thirty-one
LDCY trials of ten patients. LDCY chemotherapy significantly decreased the IAP levels in cancer
patients with high IAP levels. These results suggested that LDCY chemotherapy could counteract
host responses against tumors and could have decreased immunosuppressive responses in cancer
patients.
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